Hypothesis

We propose that a specific shift in the aging gut microbiome toward increased production of bacterially derived D‑amino acids and reduced indole‑propionic acid creates a circulating metabolite signature that directly drives microglial epigenetic reprogramming, thereby initiating inflammaging. Restoring youthful metabolite ratios via targeted prebiotic‑probiotic interventions will reverse epigenetic age markers in microglia and improve cognitive performance in aged mice.

Mechanistic Basis

Recent work shows that digital twins can capture bidirectional gut‑brain signaling and link microbiome metabolites to neuroinflammation [1, 3]. Building on this, we note two mechanistic gaps:

1. Microbial D‑amino acids (e.g., D‑serine, D‑alanine) accumulate with age and act as endogenous agonists at NMDA‑receptor‑linked microglial pathways, promoting NF‑κB activation [3].
2. Indole‑propionic acid (IPA), a tryptophan‑derived metabolite produced by certain Clostridia, functions as a ligand for the pregnane X receptor (PXR) in microglia, suppressing histone deacetylase activity and maintaining a youthful epigenome [4].

We hypothesize that the age‑related decline in IPA‑producing taxa and rise in D‑amino‑acid‑producing taxa alters the D‑AA/IPA ratio in systemic circulation. This ratio serves as a microbial metabolite clock that predicts microglial DNA methylation age (DNAmAge) and downstream cytokine release (IL‑1β, TNF‑α).

Predictions & Experimental Design

• Prediction 1: Longitudinal sampling of feces and serum from mice aged 6, 12, and 18 months will show a progressive increase in the D‑AA/IPA ratio that correlates with hippocampal microglial DNAmAge (measured by epigenetic clocks such as Horvath’s mouse clock).
• Prediction 2: Administration of a defined synbiotic (IPA‑producing Clostridium sporogenes plus a D‑amino‑acid oxidase‑expressing probiotic) will normalize the D‑AA/IPA ratio within 4 weeks, reduce microglial DNAmAge by ~15%, and improve performance in the Morris water maze.
• Prediction 3: Germ‑free mice colonized with aged‑donor microbiota will exhibit an elevated D‑AA/IPA ratio and accelerated microglial DNAmAge compared to those colonized with young‑donor microbiota, confirming causality.

Experimental approach:

• Use 16S rRNA sequencing and targeted metabolomics (LC‑MS/MS) to quantify D‑serine, D‑alanine, and IPA.
• Isolate hippocampal microglia via FACS, perform whole‑genome bisulfite sequencing to compute DNAmAge.
• Apply the synbiotic or vehicle control in a randomized, blinded design (n=10 per group).
• Assess cognition, cytokine ELISA, and microglial morphology (Iba1 staining).

Potential Outcomes & Falsifiability

If the D‑AA/IPA ratio fails to predict microglial DNAmAge or the synbiotic does not alter the ratio, DNAmAge, or behavior, the hypothesis is falsified. Conversely, a consistent inverse correlation between the metabolite ratio and epigenetic age, coupled with rescue by the synbiotic, would support the model and suggest a novel lever for mitigating inflammaging via microbiome‑targeted metabolomics.